Squamous Cell Carcinoma of Head and Neck
2 competing products in clinical development for Squamous Cell Carcinoma of Head and Neck.
Pipeline by Phase
Phase 1/21
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib + Pembrolizumab + Docetaxel + Capecitabine + Paclitaxel + Cetuximab + Lenvatinib | Eisai | Phase 2 | Completed | 35 |
| AFM24 + SNK01 | Affimed | Phase 1/2 | Terminated | 14 |